Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Adrian A. Kyriakopoulos"'
Autor:
Hans W. Ruelius, Richard I. Shader, David J. Greenblatt, Adrian A. Kyriakopoulos, Samuel F. Sisenwine, Roger T. Schillings, John Knowles
Publikováno v:
Clinical Pharmacology & Therapeutics. 20:329-341
Eight healthy male subjects received single 2-mg oral doses of lorazepam containing 24 muCi/mg of 2-14C-lorazepam. Multiple venous blood samples were drawn during the first 96 hr after the dose, and all urine and stool were collected for 120 hr after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3de1802978ddbd6ee1972d5850237d5f
https://doi.org/10.1002/cpt1976203329
https://doi.org/10.1002/cpt1976203329
Autor:
Adrian A. Kyriakopoulos, Roger H Meacham, Michael Emmett, Robert G. Narins, Soong T. Chiang, Martin Goldberg, Hans W. Ruelius, Barry R. Walker
Publikováno v:
Clinical Pharmacology and Therapeutics. 27:44-52
Capsules containing either 16 or 32 mg of 14C-guanabenz were given to 8 hypertensive patients. Maximum concentrations of guanabenz in plasma (1.2 to 5.2 ng/ml) were reached at 2 to 5 hr after dosing. 14C elimination into urine was 79.7 ± 10.6% (SD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::296aba0c5a1c7dc50543a83fbccc801c
https://doi.org/10.1038/clpt.1980.7
https://doi.org/10.1038/clpt.1980.7
Publikováno v:
Arthritis & Rheumatism. 3:129-139
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::048a3c35c7b0c7137c69f9a4076dfbab
https://doi.org/10.1002/art.1780030204
https://doi.org/10.1002/art.1780030204
Autor:
Adrian A. Kyriakopoulos
Publikováno v:
Annals of Internal Medicine. 107:941
Excerpt To the editor: Kremer and colleagues (1) reported "measurable, statistically significant alterations in disease activity" in patients with active rheumatoid arthritis after the administrati...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abdead0a51b10301e1befd68d71e313a
https://doi.org/10.7326/0003-4819-107-6-941_2
https://doi.org/10.7326/0003-4819-107-6-941_2